Lexington, KY – The United States Dressage Federation (USDF) is pleased to announce that Luitpold Pharmaceuticals, Inc. manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), the official joint therapy sponsor of USDF, has expanded its sponsorship to include the Adequan®/USDF FEI-Level Trainers Conference.
This complements their ongoing sponsorship of the Adequan®/USDF Year-End Awards, the Adequan ® /USDF Annual Convention, and the US Dressage Finals presented by Adequan®.
USDF Executive Director Stephan Hienzsch adds, “We are thrilled to be able to expand our long standing partnership with Adequan® i.m. to include the very popular USDF FEI-Level Trainers Conference.
The commitment of Luitpold Pharmaceuticals, in support of USDF and the dressage community, has made a very positive impact on the sport.” Please see Important Safety Information for Adequan® i.m. below and for more information about Adequan ® i.m., visit www.adequan.com.
“We are very excited to have the opportunity to support this conference,” stated Allyn Mann, Director at Luitpold Animal Health. “The quality of instructors, riders, and horses offers a valuable program for the dressage community.”